secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0001104659-25-058141
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus Biotherapeutics shareholders approve all proposals at 2025 AGM
------------------------------------------------------------------------

- Resolutions to re-elect directors Pierre A. Morgon and Joseph C. Scheeren passed with ~98.9% of votes cast.
- PricewaterhouseCoopers LLP re-appointed as U.K. statutory auditors and ratified as independent auditor for FY2025.
- Shareholders approved director remuneration policy and advisory compensation report for FY2024.
- No dividend recommended for FY2024; statutory accounts received and noted.
- Quorum achieved with 26,993,016 ordinary shares present or represented (66.9% of entitled shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465925058141/0001104659-25-058141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465925058141/tm2517545d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer